SEC Form 4 · accession 0001250853-16-000145
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herbert D Montgomery
Director
Period of report
Apr 15, 2016
Accepted (ET)
Apr 15, 2016 · 8:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.52 | Apr 15, 2016 | A | 27,500 | A | — | Apr 15, 2026 | Common Stock | 27,500 | 27,500 | D |
Explanation of responses
- F1The option will vest quarterly as to 25% of the shares following the date of grant.